Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress

Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress

Unusual Whales

Aug 6, 2026 at 06:34 AM

The recent acquisition of AZSTARYS® has bolstered our ADHD portfolio, leading to an extension of our long-term revenue outlook. This strategic move has significantly enhanced our offerings in the ADHD treatment space, ultimately increasing our potential for revenue growth.

Source: Unusual Whales The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Collegium Pharma

COLL.US

Open

--

High

--

Low

--

Prev Close

--

P/E^TTM

--

Market Cap

--

LongbridgeAI